ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT01717911
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT01717911
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT01717911. Randomized; no masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Insulin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Sitagliptin
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
Record details
- Record id
cardio:ct-nct01717911- Content hash
663057f02cb098e67259b933f0742ef9289331693a85abc2ba971306cd5a2dee